Skip to main content

Table 2 Clinical characteristics of study patients (N = 225)

From: c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Variable

n (%)

Stage (n = 214)

 

   I

40 (18.7)

   II

113 (52.8)

   III

53 (24.8)

   IV

8 (3.7)

T (n = 222)

 

   T1

59 (26.6)

   T2

106 (47.7)

   T3

27 (12.2)

   T4

30 (13.5)

N (n = 222)

 

   N0

94 (42.3)

   N1

112 (50.5)

   N2-3

16 (7.2)

Grading (n = 220)

 

   G1/G2

151 (68.6)

   G3

69 (31.4)

Histology (n = 225)

 

   Ductal

175 (77.8)

   Lobular

22 (9.8)

   All other subtypes

28 (12.4)

Menopausal (n = 163)

 

   Premenopausal

43 (26.4)

   Postmenopausal

120 (73.6)

ER (n = 212)

 

   Positive

135 (63.7)

   Negative

77 (36.3)

PR (n = 211)

 

   Positive

127 (60.2)

   Negative

84 (39.8)

Metastasis (n = 218)

 

   Negative

210 (96.3)

   Positive

8 (3.7)

  1. ER, estrogen receptor; N, palpable nodes; PR, progesterone receptor; T, tumor size.